Cover image of the article: Clinical manifestations of MPGN in children  comparing their responsiveness to drug treatment

Image Credit:J Inflamm Dis

Clinical manifestations of MPGN in children comparing their responsiveness to drug treatment

Authors

D Fahimi, A Madani,*, ST Esfehani, P Mohseni, A Broujerdi, M Haddadi
*Corresponding Author: Email: amadani@mail.com

Journal of Inflammatory Diseases:Vol. 6, issue 4; 62-67
Published online:Mar 31, 2003
Article type:Research Article
How to Cite:Fahimi D, Madani A, Esfehani S, Mohseni P, Broujerdi A, et al. Clinical manifestations of MPGN in children comparing their responsiveness to drug treatment. J Inflamm Dis. 2024;6(4):e154913. doi:

Abstract

Abstract Background: Membranoproliferative glomerulonephritis (MPGN) is the most common type of chronic glomerulonephritis in children. Objective: To determine clinical manifestations of MPGN in Iranian children and to compare their responsiveness to drug regimens (steroids & immunosurppressives). Methods: The medical records of the patients from June 1972 to January 1996 were reviewed. Age of onset of disease, sex, creatinine clearance, initial clinical presentation, presence or absence of pathologic proteinuria, hematuria, hypertension and low serurm C3 level in each patient & also the responsiveness of those who had follow- up drug treatment were examined . Using T test & x 2 test the means were compared (P À0.05). Findings: 66 cases were reported: type I 55 patients, type II 7 patients and type III 4 patients. 31 patients were male. There was no significant correlation between sex, pathologic proteinuria and hematuria and progression to CRF but more patients who had hypertension progressed to CRF (P<0.05). Patients with initial clinical presentations of rapidly progressive glomerulonephritis and chronic glomerulonephritis had worse prognosis and more progress to CRF (P<0.05). Patients who had received specific treatment had better prognosis (P<0.05). Conclusion: MPGN has the potential for progressing to CRF. Long-term treatment with steroids and immunosurppressive drugs may prohibit this progression.

Highlights

Copyright

© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

22
Mar
2005
Various types of glomerulonephritis in children in south Iran

Various types of glomerulonephritis in children in south Iran

F Emam Ghoreushi,
N Namdari Forghani,
Fatemeh Shahbazi

Emam Ghoreushi F, Namdari Forghani N, Shahbazi F. Various types of glomerulonephritis in children in south Iran. Zahedan J Res Med Sci. 2005;7(1):e94970. doi:

21
Aug
2017
Crescentic Glomerulonephritis in a Sub-Saharan Country: Clinical Presentation, Etiological and Evolutive Profile

Crescentic Glomerulonephritis in a Sub-Saharan Country: Clinical Presentation, Etiological and Evolutive Profile

Maria Faye,
Ahmed Tall Lemrabott,
Khodia Fall,
Mohamed Moustapha Cherif Dial,
Mouhamadou Moustapha Cisse,
Nisrine El Boumaoui
,et al.

Faye M, Tall Lemrabott A, Fall K, Moustapha Cherif Dial M, Moustapha Cisse M, et al. Crescentic Glomerulonephritis in a Sub-Saharan Country: Clinical Presentation, Etiological and Evolutive Profile. Nephro-Urol Mon. 2017;9(6):e60365. doi: https://doi.org/10.5812/numonthly.60365

15
May
2005
Study of some prognostic factors of progress to end-stage renal failure in patients with rapidly progressive glomerulonephritis in Hasheminejad hospital

Study of some prognostic factors of progress to end-stage renal failure in patients with rapidly progressive glomerulonephritis in Hasheminejad hospital

MohammadReza Tamadon,
AliReza Soleymani,
Jafar Tosi

Tamadon M, Soleymani A, Tosi J. Study of some prognostic factors of progress to end-stage renal failure in patients with rapidly progressive glomerulonephritis in Hasheminejad hospital. koomesh. 2005;6(3):e152061. doi:

22
May
2018
Nephrotic Syndrome Outcome in Children: An Epidemiological Study

Nephrotic Syndrome Outcome in Children: An Epidemiological Study

Parsa Yousefichaijan,
Masoud Rezagholizamenjany,
Fatemeh Rafiei,
Ali Arjmand,
Sima Tayebi

Yousefichaijan P, Rezagholizamenjany M, Rafiei F, Arjmand A, Tayebi S. Nephrotic Syndrome Outcome in Children: An Epidemiological Study. J Compr Ped. 2018;9(4):e62514. doi: https://doi.org/10.5812/compreped.62514

2
Oct
2021
Remissions in Patients with Idiopathic Membranous Nephropathy Treated with Rituximab in Senegal

Remissions in Patients with Idiopathic Membranous Nephropathy Treated with Rituximab in Senegal

Moustapha Faye,
Fabrice Arnold Tcheumagam Tiako,
Ahmed Tall Lemrabott,
Bacary Ba,
Niakhaleen Keita,
Modou Ndongo
,et al.

Faye M, Tiako FAT, Lemrabott AT, Ba B, Keita N, et al. Remissions in Patients with Idiopathic Membranous Nephropathy Treated with Rituximab in Senegal. Nephro-Urol Mon. 2021;13(4):e117467. doi: https://doi.org/10.5812/numonthly.117467

More by these authors

ST EsfehaniPubMedScholar
P MohseniPubMedScholar
A BroujerdiPubMedScholar
M HaddadiPubMedScholar
Share
Cited by
Metrics